Symmetrical Triangle Pattern Suggests a Significant Move in Ligand Pharmaceuticals Soon

A symmetrical triangle pattern has emerged in the chart of Ligand Pharmaceuticals (LGND).  After this period of consolidation, we expect the stock to breakout or breakdown…

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

Take a look at the 1-year chart of Ligand (LGND – Get Rating) below with my added notations…

See chart and continue reading at STOCKNEWS.com